Intraoperative Radiation Therapy Market Size, Share, Trends, & Industry Analysis Report
By Method, By Products and Services, By Application, By End User, and By Region – Market Forecast, 2025–2034
- Published Date:Oct-2025
- Pages: 126
- Format: PDF
- Report ID: PM6500
- Base Year: 2024
- Historical Data: 2020-2023
Overview
The intraoperative radiation therapy market was valued at USD 322.67 million in 2024 growing at a CAGR of 7.27% from 2025-2032. Rising global cancer incidence coupled with increasing healthcare expenditure across emerging economies is driving the demand for intraoperative radiation therapy solutions.
Key Insights
- Electron IORT segment dominated in 2024 due to precise radiation delivery and growing clinical adoption.
- Specialty clinics segment is expected to grow fastest, driven by outpatient care and minimally invasive procedures.
- North America led the global market in 2024 due to advanced healthcare infrastructure.
- The U.S. dominated North America in 2024 with high healthcare spending and hospital investments.
- Asia Pacific is projected to record the fastest growth, driven by rising cancer prevalence and expanding oncology facilities.
- China led Asia Pacific due to government support and growing investments in advanced cancer care.
Industry Dynamics
- Rising cancer incidence is driving demand for intraoperative radiation therapy.
- Growing healthcare spending is supporting advanced oncology solutions.
- High setup costs are limiting adoption in smaller hospitals.
- IORT integration with image-guided and robotic-assisted surgery creates growth opportunities.
Market Statistics
- 2024 Market Size: USD 322.67 Million
- 2034 Projected Market Size: USD 650.27 Million
- CAGR (2025-2034): 7.27%
- North America: Largest Market Share
Intraoperative radiation therapy (IORT) provides focused cancer therapy by delivering a concentrated dose of radiation during surgery, with a reduced exposure to surrounding healthy tissue. It combines advanced imaging, radiation delivery, and surgical precision technologies to enhance local tumor control and decrease postoperative complications.
Increasing global cancer incidence and increasing healthcare spending are driving the adoption of IORT systems at oncology centers. Medical professionals are increasingly investing in efficient, one-session radiotherapy procedures that is expected to improve treatment speed and patient recovery rates. Some hospitals have added oncology services with mobile IORT units to increase access and procedure convenience. For example, in September of 2025, Accuray introduced the Stellar system, a single-platform radiotherapy solution for improving intraoperative radiation oncology therapy through real-time imaging and adaptable treatment.
Hospitals and cancer treatment centers geographically are embracing state-of-the-art IORT platforms to handle greater patient volumes and improve treatment accuracy. Top vendors are launching image-guided, AI-enabled, and transportable IORT solutions to aid personalized treatment planning, real-time dose optimization, and streamlined workflow integration in surgical oncology settings.
Drivers & Opportunity
Rising global cancer incidence due to aging populations: Increasing incidence of cancer globally along with rising aging population is driving the intraoperative radiation therapy industry. New cases of cancer, as estimated by World Health Organization (WHO), are predicted to reach more than 35 million in 2050, up 77% from approximately 20 million cases in 2022. Older patients have increased cancer risk, putting a greater need for targeted and accurate treatments. Hospitals are building out oncology capacity to handle increasing caseloads. This movement allows for the integration of new radiation technologies to drive better results.
Increasing healthcare expenditure across emerging economies: Growing healthcare spending in developed and emerging markets is solidifying cancer care infrastructure. Private providers and governments are making investments in advanced oncology equipment. Expanding budgets allow for greater access to sophisticated systems like IORT. The investment is enhancing the efficiency of treatment and global patient care standards.
Segmental Insights
Method Analysis
On the basis of method, the segmentation comprises of electron IORT, intraoperative brachytherapy, and other methods. The electron IORT segment led the market in 2024 owing to its sharp delivery of radiation with minimal damage to the surrounding tissues.
The intraoperative brachytherapy is projected to register the fastest CAGR during the forecast period due to technological advancements in radioactive seed implantation. In addition, increasing clinical acceptance for localized tumor control supports its rapid adoption.
Products and Services Analysis
Based on products and services, the segmentation includes products and services. The products segment dominated the market in 2024 due to high demand for IORT devices and radiation delivery systems. Moreover, continuous upgrades in device efficiency and precision are supporting sustained product adoption worldwide.
The services segment is expected to grow at the fastest CAGR due to increasing hospital reliance on procedural support, maintenance, and training services. In addition, expanding awareness of professional guidance in IORT usage is driving growth.
Application Analysis
Based on application, the segmentation includes breast cancer, brain tumor, gastro-intestinal cancer, head and neck cancer, and other applications. The breast cancer segment dominated the market in 2024 as IORT provides effective single-session radiotherapy. According to WHO’s 2025 report, in 2022, about 2.3 million women were diagnosed with breast cancer and 670,000 died worldwide, with risk increasing with age after puberty. Moreover, growing awareness among patients and clinicians about reduced treatment time is increasing its adoption globally.
The brain tumor segment is projected to grow at the fastest CAGR due to rising prevalence and adoption of precise intraoperative radiation techniques. In addition, technological innovations supporting safer and targeted therapy are fueling demand.
End User Analysis
Based on end user, the segmentation includes hospitals, specialty clinics, and others. The hospitals led the market in 2024 owing to high procedural volumes and well-established oncology infrastructure. In addition, increasing investment in state-of-the-art radiotherapy equipment is fueling adoption of IORT within multi-specialty hospital networks.
The specialty clinics are anticipated to exhibit the highest CAGR as they continue to provide focused radiotherapy treatments. Furthermore, growing patient demand for outpatient treatment and minimally invasive procedures is driving adoption in these facilities.
Regional Analysis
North America held the largest share in the IORT market in 2024 with increasing cancer incidence among aging populations. Additionally, the availability of established oncology infrastructure facilitates extensive adoption of state-of-the-art IORT systems. In addition, favorable reimbursement policies in the U.S. are enabling hospitals to invest in cutting-edge radiation technologies.
The U.S. Intraoperative Radiation Therapy Market Insights
The U.S. dominated the intraoperative radiation therapy industry owing to high healthcare expenditure and advanced cancer care facilities. The U.S. Department of Health and Human Services estimated that in 2025, around 2,041,910 new cancer cases projected to diagnosed in the U.S., with 618,120 deaths expected. Moreover, increasing clinical adoption of minimally invasive radiotherapy procedures is supporting rapid integration of IORT solutions. In addition, growing patient awareness enhances treatment growth.
Europe Intraoperative Radiation Therapy Market Insights
Europe held the substantial share in the intraoperative radiation therapy market due to the widespread adoption of advanced cancer treatment technologies. Moreover, increasing government support for oncology centers is facilitating integration of IORT systems. In addition, high patient preference for single-session radiotherapy is driving procedural volumes.
Asia Pacific Intraoperative Radiation Therapy Market Insights
Asia Pacific is the fastest growing market driven by increasing cancer incidence and rising healthcare investments in emerging economies. According to Invest India, India’s healthcare sector is growing rapidly, with the home healthcare market expected to reach USD 21.3 billion by 2027, and the overall industry achieving a CAGR of around 22% since 2016. Moreover, expanding hospital infrastructure in countries such as China and India is promoting the adoption of advanced IORT systems. In addition, growing awareness about localized radiotherapy procedures is driving market expansion.
China Intraoperative Radiation Therapy Market Insights
China intraoperative radiation therapy market growth is fueled by government initiatives to strengthen cancer care infrastructure. Additionally, private hospital investments in cutting-edge radiotherapy equipment are upgrading procedural capability. In addition, rapid urbanization is increasing access to modern oncology centers.
Key Players & Competitive Analysis Report
The intraoperative radiation therapy market is moderately competitive, with companies advancing imaging, radiation delivery, and surgical precision technologies. Additionally, investment in portable IORT units, treatment planning systems and advanced image processing, and collaboration with hospitals and oncology centers improve procedural efficiency, treatment precision, and international market presence.
Major companies operating in the intraoperative radiation therapy market include Elekta AB, Eckert & Ziegler SE, iCAD Inc., RaySearch Laboratories, IntraOp Medical Corporation, GMV Innovating Solutions S.L., Sensus Healthcare, Inc., Ariane Medical Systems Ltd, S.I.T. Sordina IORT Technologies S.p.A., Isoray Inc., Varian Medical Systems Inc., and Carl Zeiss Meditec AG.
Key Players
- Ariane Medical Systems Ltd
- Carl Zeiss Meditec AG
- Eckert & Ziegler SE
- Elekta AB
- GMV Innovating Solutions S.L.
- IntraOp Medical Corporation
- iCAD Inc.
- Isoray Inc.
- RaySearch Laboratories
- S.I.T. Sordina IORT Technologies S.p.A.
- Sensus Healthcare, Inc.
- Varian Medical Systems Inc.
Industry Development
- April 2025: ZEISS received FDA approval for its INTRABEAM 700 system, a robotic-based platform that optimizes precision and workflow within intraoperative radiation therapy in cancer surgery.
- October 2024: Aster Whitefield Hospital in Bengaluru launched India’s first IOeRT, providing targeted intraoperative radiation to treat cancer more precisely and reduce post-surgery sessions.
Intraoperative Radiation Therapy Market Segmentation
By Method (Revenue, USD Million, 2020–2034)
- Electron IORT
- Intraoperative Brachytherapy
- Other Methods
By Products and Services (Revenue, USD Million, 2020–2034)
- Products
- Systems and Accelerators
- Applicators & Afterloaders
- Treatment Planning Systems
- Accessories
- Services
By Application (Revenue, USD Million, 2020–2034)
- Breast Cancer
- Brain Tumor
- Gastro-intestinal Cancer
- Head and Neck Cancer
- Other Applications
By End User (Revenue, USD Million, 2020–2034)
- Hospitals
- Specilaty Clinics
- Others
By Region (Revenue, USD Million, 2020–2034)
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Latin America
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of South Africa
Intraoperative Radiation Therapy Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 322.67 Million |
|
Market Size in 2025 |
USD 345.82 Million |
|
Revenue Forecast by 2034 |
USD 650.27 Million |
|
CAGR |
7.27% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2025-2034 |
|
Forecast Period |
2025-2034 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Application |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions and segmentation. |
FAQ's
The global market size was valued at USD 322.67 million in 2024 and is projected to grow to USD 650.27 million by 2034.
The global market is projected to register a CAGR of 7.27% during the forecast period.
North America dominated the intraoperative radiation therapy market in 2024 due to advanced healthcare infrastructure.
A few of the key players in the market are Elekta AB, Eckert & Ziegler SE, iCAD Inc., RaySearch Laboratories, IntraOp Medical Corporation, GMV Innovating Solutions S.L., Sensus Healthcare, Inc., Ariane Medical Systems Ltd, S.I.T. Sordina IORT Technologies S.p.A., Isoray Inc., Varian Medical Systems Inc., and Carl Zeiss Meditec AG.
The electron IORT segment dominated in 2024 due to precise and localized radiation delivery.
Specialty clinics are projected to grow fastest, driven by outpatient cancer care and minimally invasive radiotherapy procedures.
© 2025 Polaris Market Research and Consulting. All rights reserved
